Identification
Personal identification
- Full name
- Dina Maria da Silva Rodrigues Pereira
Citation names
- Pereira, Dina
Author identifiers
- Ciência ID
- 6015-36DA-D03E
- ORCID iD
- 0000-0002-6723-1159
Knowledge fields
- Natural sciences - Biological Sciences - Biology
Education
Degree | Classification | |
---|---|---|
2020/01/09
Concluded
|
Biologia Experimental e Biomedicina (Doutoramento)
Major in Biotecnologia e Saúde
Instituto de Investigação Interdisciplinar da Universidade de Coimbra, Portugal
Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal ""The role of ageing in polyglutamine-induced neurodegeneration. A study in Machado-Joseph disease models"" (THESIS/DISSERTATION)
|
Louvor e distinção por unanimidade |
2008
Concluded
|
Biologia Aplicada (Licenciatura)
Universidade do Minho Escola de Ciências, Portugal
"Human Leukocyte Antigen Class I expression and infection by JC virus in right-sided colon cancer" (THESIS/DISSERTATION)
|
16 |
Affiliation
Science
Category Host institution |
Employer | |
---|---|---|
2023/07/01 - Current | Postdoc (Research) | Universidade de Coimbra Centro de Inovação em Biomedicina e Biotecnologia, Portugal |
2020/02/01 - 2023/06/30 | Postdoc (Research) | Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal |
Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal |
Others
Category Host institution |
Employer | |
---|---|---|
2012/07/02 - 2012/09/30 | Research trainee under the internal project: "Irradiation and atherosclerotic disease – epidemiologic and biologic evaluation of a cohort irradiated in childhood for tinea capitis treatment"- Cancer B | Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal |
2009/04/01 - 2012/06/30 | Research trainee (FCT grant) under the project: (FCOMP-01-0124-FEDER-008463, former ref PIC/IC/83154/2007): “Cancer risk and irradiation: an epidemiological and genetic study of a cohort irradiated fo | Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal |
Projects
Grant
Designation | Funders | |
---|---|---|
2022/11/01 - 2023/06/30 | Fighting Sars-CoV-2 with viral vectors
CENTRO-01-01D2-FEDER000002
Post-doc Fellow
Universidade de Coimbra Centro de Inovação em Biomedicina e Biotecnologia, Portugal
Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal Universidade de Coimbra, Portugal |
Universidade de Coimbra
Concluded
|
2018/01 - 2018/12 | JPCOFUND/0001/2015
JPCOFUND/0001/2015
Research Fellow
Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal
|
Concluded
|
2017/01 - 2017/12/31 | UID/NEU/04539/2013 - CNC. IBILI
UID/NEU/04539/2013
Research Fellow
CNC.IBILI, Portugal
|
Concluded
|
2012/10/01 - 2016/09/30 | SFRH / BD / 51965 / 2012
SFRH / BD / 51965 / 2012
PhD Student Fellow
Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal
|
Fundação para a Ciência e a Tecnologia
Ongoing
|
2009/04/01 - 2012/06 | FCOMP-01-0124-FEDER-008463, former ref PIC/IC/83154/2007
FCOMP-01-0124-FEDER-008463, former ref PIC/IC/83154/2007
Research Fellow
|
Fundação para a Ciência e a Tecnologia
Concluded
|
Contract
Designation | Funders | |
---|---|---|
2023/07/01 - Current | CiNTech - Technological Hub for Innovation, Translation and Industrialization of Complex Injectable Drugs
C644865576-00000005
Researcher
Universidade de Coimbra Centro de Inovação em Biomedicina e Biotecnologia, Portugal
Universidade de Coimbra, Portugal Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal |
Universidade de Coimbra
Ongoing
|
Other
Designation | Funders | |
---|---|---|
2020/02/01 - 2022/10 | Calpain inhibition as a therapeutic strategy in Machado-Joseph disease
CPD0020A01
Post-doc Fellow
Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal
|
Blade Therapeutics, Inc.
Concluded
|
2019/01/01 - 2020/01/31 | Calpain inhibition as a therapeutic strategy in Machado-Joseph Disease
CPD0020A01
Research Fellow
Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal
|
Blade Therapeutics, Inc.
Concluded
|
Outputs
Publications
Book chapter |
|
Conference abstract |
|
Conference paper |
|
Conference poster |
|
Journal article |
|
Preprint |
|
Activities
Oral presentation
Presentation title | Event name Host (Event location) |
|
---|---|---|
2024/01 | Targeted silencing via AAV9 polycistronic microRNA therapy rescues SCA3 molecular, neuropathological and motor deficits. | 54 th Meeting of the Portuguese Society of Pharmacology, 42 nd Meeting of Clinical Pharmacology and 23 rd Meeting of Toxicology
Portuguese Society of Pharmacology (Lisbon, Portugal)
|
2023/03 | Let's make a puzzle: unravelling how Mesenchymal Stromal Cells decrease mutant ataxin-3 levels and promote ameliorations in Machado-Joseph Disease? | DCV.talks - Departamento das Ciências e da Vida (DCV)
Departamento das Ciências e da Vida (DCV) (Coimbra, Portugal)
|
2023/02 | Investigating the clock components and circadian activity in the YAC-MJD mouse model. | 53rd Meeting of the Portuguese Society of Pharmacology, 41st Meeting of Clinical Pharmacology and 22nd Meeting of Toxicology
Portuguese Society of Pharmacology (Coimbra, Portugal)
|
2022/12 | Mesenchymal Stem Cells for Brain Disorders: the Particular case of Machado-Joseph Disease. | Seminar given inside the Gene and Cell Therapy Curricular Unit from the Biomedical Sciences Graduation
Biomedical Sciences Graduation - Algarve University (Portugal)
|
2022/02 | Non-pathogenic viral vectors pseudotyped with the SARS-CoV-2 S protein to study drug repurposing and immunization strategies. | 52ª Reunião da Sociedade Portuguesa de Farmacologia
Sociedade Portuguesa de Farmacologia (Porto, Portugal)
|
2022 | Engineered nucleases targeting the ATXN3 gene for the therapy of Machado-Joseph disease. Flash Talk Presentation. | 27th European Society for Animal Cell Technology Meeting (ESACT2022)
European Society for Animal Cell Technology (Lisbon, Portugal)
|
2021/12 | Non-pathogenic viral vectors pseudotyped with the SARS-CoV-2 S protein to study drug repurposing and immunization strategies. | CIBB Annual Meeting
Centre for Innovative Biomedicine and Biotechnology (CIBB) (Coimbra, Portugal)
|
2021/06 | Blood-brain barrier (BBB) disruption is a shared feature for several neurodegenerative diseases. | 55TH ANNUAL SCIENTIFIC MEETING OF the European Society of Clinical Investigation (ESCI) – Online Event
European Society of Clinical Investigation (ESCI)
|
2021/02 | Importin-8 Silencing Prevents Mutant Ataxin-3 Aggregation And Delays Machado-Joseph Disease Progression. | 51.ª Reunião da Sociedade Portuguesa de Farmacologia, 39.ª Reunião de Farmacologia Clínica e 20ª Reunião de Toxicologia
Sociedade Portuguesa de Farmacologia (Lisbon, Portugal)
|
2019/12 | MSC Success in Promoting Ameliorations in Machado-Joseph Disease - Where do We Stand and Where We Should Go? | Center for Innovative Biomedicine and Biotechnology (CIIB) Meeting in Coimbra
Centre for Innovative Biomedicine and Biotechnology (CIBB) (Coimbra, Portugal)
|
2019/11 | Reinstating levels of dysregulated autophagy-associated transcripts alleviates neuropathology and motor impairments of mouse models of Machado-Joseph disease. | 2019 International Machado-Joseph Research Disease Conference. Washington, DC. USA
(Washington, DC, United States)
|
2019/11 | Reinstating levels of dysregulated autophagy-associated transcripts alleviates neuropathology and motor impairments of mouse models of Machado-Joseph disease. | International Research Ataxia Conference (IARC)
(Washington, DC, United States)
|
2019/11 | Machado-Joseph Disease: the role of ageing in polyglutamine-induced neurodegeneration. | 1st Annual Meeting in Pharmaceutical Sciences
Pharmacy Faculty of UC (Coimbra, Portugal)
|
2019/05 | Blood-brain barrier dysfunction as a neuropathological feature in Machado-Joseph Disease: Results from mouse and human brain tissues. | XVI Meeting of the Portuguese Society for Neuroscience (SPN2019)
Portuguese Society for Neuroscience (Lisbon, Portugal)
|
2019/05 | Sustainable phenotypic ameliorations in Machado-Joseph Disease/Spinocerebelar ataxia type-3 can be reached by repeated systemic administrations of mesenchymal stromal cells – and can be monitored through proton Magnetic Resonance Spectroscopy biomarkers. | XVI Meeting of the Portuguese Society for Neuroscience (SPN2019)
Portuguese Society for Neuroscience (Lisbon, Portugal)
|
2019/02 | Disruption of Blood-Brain Barrier in Machado-Joseph Disease. | XLIX Reunião da Sociedade Portuguesa de Farmacologia, XXXVII Reunião de Farmacologia clínica, XVIII Reunião de toxicologia.
Sociedade Portuguesa de Farmacologia (Porto, Portugal)
|
2019 | Blood-brain barrier dysfunction as a neuropathological feature in Machado-Joseph Disease. | 1st Annual Meeting in Pharmaceutical Sciences
Pharmacy Faculty of UC (Coimbra, Portugal)
|
2019 | DISRUPTION OF BLOOD-BRAIN BARRIER IN MACHADO-JOSEPH DISEASE. | XLIX Reunião da Sociedade portuguesa de Farmacologia; XXXVII Reunião de Farmacologia Clínica; XVIII Reunião de Toxicologia
Sociedade Portuguesa de Farmacologia (Porto, Portugal)
|
2018/07 | Neuropeptide Y rescues aging phenotype of human Hutchinson-Gilford Progeria syndrome fibroblasts. | 18th World Congress of Basic and Clinical Pharmacology (WCP2018)
(Kyoto, Japan)
|
2018/02 | "The role of ageing in polyglutamine-induced neurodegeneration. A Study in Machado-Joseph disease models" | XLVIII Reunião Anual da Sociedade Portuguesa de Farmacologia
Sociedade Portuguesa de Farmacologia (Lisboa, Portugal)
|
2018/02 | "Reinstating levels of dysregulated autophagy-associated transcripts alleviates neuropathology and motor impairments of mouse models of Machado-Joseph disease" | XLVIII Reunião Anual da Sociedade Portuguesa de Farmacologia
Sociedade Portuguesa de Farmacologia (Lisboa, Portugal)
|
2017/02 | "Is ageing the triggering factor in polyglutamine-induced neurodegeneration? A study in Machado-Joseph disease models" | XLVII Reunião Anual Da Sociedade Portuguesa De Farmacologia, XXXV Reunião De Farmacologia Clínica, XVI Reunião de Toxicologia
Sociedade Portuguesa de Farmacologia (Coimbra, Portugal)
|
2017/02 | Ghrelin ameliorates the senescent phenotype of human Hutchinson-Gilford progeria syndrome cells. | XLVII Reunião Anual Da Sociedade Portuguesa De Farmacologia, XXXV Reunião De Farmacologia Clínica, XVI Reunião de Toxicologia
Sociedade Portuguesa de Farmacologia (Coimbra, Portugal)
|
2017/01 | Is ageing the triggering factor in polyglutamine-induced neurodegeneration? A study in Machado-Joseph disease models. | BEB DAY - Not So Usual Insights Into a PhD
Center for Neuroscience and Cell Biology (CNC), University of Coimbra (Coimbra, Portugal)
|
2016 | NPY reverts HGPS phenotype. | 8th Progeria Research Foundation International Scientific Workshop ¿ Across the Table, Around the Globe, Cambridge, MA, USA.
Progeria Research Foundation (Cambridge, MA, United States)
|
Supervision
Thesis Title Role |
Degree Subject (Type) Institution / Organization |
|
---|---|---|
2022 - Current | Jisette Nuñez - Título da tese : Drug repurposing, immunological surveillance, and vaccine development for COVID-19 - Entidade
financiadora: Fundação para a Ciência e a Tecnologia, Referência da bolsa: 2022.12572.BD
Orientadores: Luís Pereira de Almeida e Dina Pereira
Co-supervisor
|
|
2020/09/21 - 2021/11/19 | Non-pathogenic viral vectors of SARS-CoV-2 to study drug repurposing and immunization strategies
Supervisor
|
Biotecnologia Farmacêutica (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal
|
Event organisation
Event name Type of event (Role) |
Institution / Organization | |
---|---|---|
2014 - 2014 | Member of the Organizing Committee for the CNC Annual Meeting, University of Coimbra (2014 - 2014)
Conference (Member of the Organising Committee)
|
Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal |
2013 - 2013 | Member of the Organizing Committee for the 2nd BEB Symposium (2013 - 2013)
Symposium (Member of the Organising Committee)
|
Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal |
2007 - 2007 | Member of the Organizing Committee for the Annual Applied Biology Conferences “IX Jornadas de Biologia Aplicada" (2007 - 2007)
Conference
|
Universidade do Minho, Portugal |
Distinctions
Other distinction
2011 | 2ª edição do prémio ACS-Merck Serono – Epidemiologia do Cancro |